Abstract:Successfully reprogramming somatic cells to a pluripotent state generates induced pluripotent stem (iPS) cells (or iPSCs), which have extensive self-renewal capacity like embryonic stem cells (ESCs). iPSCs can also generate daughter cells that can further undergo differentiation into various lineages or terminally differentiate to reach their final functional state. The discovery of how to produce iPSCs opened a new field of stem cell research with both intellectual and therapeutic benefits. The huge potential implications of disease-specific or patient-specific iPSCs have impelled scientists to solve problems hindering their applications in clinical medicine, especially the issues of convenience and safety. To determine the range of tissue types amenable to reprogramming as well as their particular characteristics, cells from three embryonic germ layers have been assessed, and the advantages that some tissue origins have over fibroblast origins concerning efficiency and accessibility have been elucidated. To provide safe iPSCs in an efficient and convenient way, the delivery systems and combinations of inducing factors as well as the chemicals used to generate iPSCs have also been significantly improved in addition to the efforts on finding better donor cells. Currently, iPSCs can be generated without c-Myc and Klf4 oncogenes, and non-viral delivery integration-free chemically mediated reprogramming methods have been successfully employed with relatively satisfactory efficiency. This paper will review recent advances in iPS technology by highlighting tissue origin and generation of iPSCs. The obstacles that need to be overcome for clinical applications of iPSCs are also discussed.

Choices for Induction of Pluripotency: Recent Developments in Human Induced Pluripotent Stem Cell Reprogramming Strategies

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Advances in Reprogramming of Peripheral Blood Cells to Induced Pluripotent Stem Cells

Improving the Reprogramming Efficiency of Somatic Cells to Induced Pluripotent Stem Cells.

Evolution of Induced Pluripotent Stem Cell Technology

Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming

Progress and Bottleneck in Induced Pluripotency.

Inducing Pluripotency in Somatic Cells: Historical Perspective and Recent Advances

Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins.

Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells

Advances in Reprogramming Somatic Cells to Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery Behind Reprogramming

Advances in understanding the cell types and approaches used for generating induced pluripotent stem cells

Proteins Reprogramming: Present and Future.

Nanotechnology in Generation and Biomedical Application of Induced Pluripotent Stem Cells

The Research Status of Induced Pluripotent Stem Cells

Impacting Factors for Induced Pluripotent Stem Cells

Progress regarding induction of pluripotent stem cells

Experimental approaches for the generation of induced pluripotent stem cells

Possible Strategies to Reduce the Tumorigenic Risk of Reprogrammed Normal and Cancer Cells

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications